Integra LifeSciences Holdings EBITDA Margin 2010-2023 | IART

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current EBITDA margin for Integra LifeSciences Holdings as of December 31, 2023 is .
Integra LifeSciences Holdings EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2023-12-31 $1.54B $0.24B 15.64%
2023-09-30 $1.54B $0.27B 17.64%
2023-06-30 $1.55B $0.31B 20.00%
2023-03-31 $1.56B $0.36B 22.73%
2022-12-31 $1.56B $0.36B 23.36%
2022-09-30 $1.57B $0.36B 22.73%
2022-06-30 $1.57B $0.35B 22.19%
2022-03-31 $1.56B $0.34B 21.79%
2021-12-31 $1.54B $0.32B 21.00%
2021-09-30 $1.53B $0.32B 20.84%
2021-06-30 $1.51B $0.33B 21.74%
2021-03-31 $1.38B $0.29B 21.34%
2020-12-31 $1.37B $0.30B 21.50%
2020-09-30 $1.38B $0.28B 19.96%
2020-06-30 $1.39B $0.19B 13.34%
2020-03-31 $1.51B $0.21B 13.89%
2019-12-31 $1.52B $0.21B 13.70%
2019-09-30 $1.51B $0.21B 13.68%
2019-06-30 $1.49B $0.25B 16.88%
2019-03-31 $1.48B $0.24B 15.93%
2018-12-31 $1.47B $0.23B 15.49%
2018-09-30 $1.46B $0.20B 13.72%
2018-06-30 $1.37B $0.18B 12.98%
2018-03-31 $1.29B $0.16B 12.43%
2017-12-31 $1.19B $0.14B 11.44%
2017-09-30 $1.08B $0.16B 14.96%
2017-06-30 $1.05B $0.18B 17.00%
2017-03-31 $1.01B $0.18B 17.75%
2016-12-31 $0.99B $0.19B 19.25%
2016-09-30 $0.98B $0.17B 17.81%
2016-06-30 $0.95B $0.15B 15.95%
2016-03-31 $0.92B $0.15B 16.14%
2015-12-31 $0.88B $0.14B 15.97%
2015-09-30 $0.80B $0.14B 17.74%
2015-06-30 $0.77B $0.14B 17.86%
2015-03-31 $0.79B $0.13B 16.31%
2014-12-31 $0.80B $0.12B 14.68%
2014-09-30 $0.73B $0.13B 18.34%
2014-06-30 $0.74B $0.09B 12.30%
2014-03-31 $0.72B $0.08B 11.47%
2013-12-31 $0.70B $0.07B 9.90%
2013-09-30 $0.83B $0.04B 5.18%
2013-06-30 $0.83B $0.10B 11.61%
2013-03-31 $0.83B $0.11B 13.12%
2012-12-31 $0.83B $0.13B 15.66%
2012-09-30 $0.82B $0.12B 14.39%
2012-06-30 $0.81B $0.12B 14.29%
2012-03-31 $0.80B $0.11B 13.58%
2011-12-31 $0.78B $0.11B 13.85%
2011-09-30 $0.77B $0.12B 15.84%
2011-06-30 $0.76B $0.13B 16.82%
2011-03-31 $0.74B $0.14B 18.49%
2010-12-31 $0.73B $0.14B 18.83%
2010-09-30 $0.72B $0.14B 19.92%
2010-06-30 $0.71B $0.14B 19.92%
2010-03-31 $0.70B $0.14B 20.14%
2009-12-31 $0.68B $0.14B 20.50%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.166B $1.542B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.942B 27.62
Intuitive Surgical (ISRG) United States $140.614B 84.71
Edwards Lifesciences (EW) United States $54.300B 35.34
DexCom (DXCM) United States $52.458B 79.46
IDEXX Laboratories (IDXX) United States $44.675B 52.37
Alcon (ALC) Switzerland $43.915B 31.47
IQVIA Holdings (IQV) United States $42.817B 24.84
STERIS (STE) Ireland $22.799B 26.64
Waters (WAT) United States $21.385B 31.43
SONOVA HOLDING (SONVY) Switzerland $19.521B 0.00
Hologic (HOLX) United States $17.492B 19.57
Fresenius Medical Care AG KGaA (FMS) Germany $13.139B 15.34
ShockWave Medical (SWAV) United States $12.422B 77.31
Sysmex ADR (SSMXY) Japan $10.769B 33.77
Teleflex (TFX) United States $10.295B 16.02
Globus Medical (GMED) United States $8.657B 25.38
Penumbra (PEN) United States $7.812B 88.78
Masimo (MASI) United States $6.403B 36.88
Glaukos (GKOS) United States $5.561B 0.00
TransMedics (TMDX) United States $4.444B 421.66
Integer Holdings (ITGR) United States $3.987B 24.09
PROCEPT BioRobotics (PRCT) United States $3.504B 0.00
LivaNova (LIVN) United Kingdom $3.405B 20.22
Tandem Diabetes Care (TNDM) United States $3.031B 0.00
Elekta AB (EKTAY) Sweden $2.942B 20.18
Inari Medical (NARI) United States $2.692B 0.00
Nihon Kohden (NHNKY) Japan $2.478B 20.95
RxSight (RXST) United States $2.303B 0.00
Veracyte (VCYT) United States $1.789B 0.00
Alphatec Holdings (ATEC) United States $1.599B 0.00
Artivion (AORT) United States $0.980B 94.00
AVANOS MEDICAL, INC (AVNS) United States $0.937B 18.23
OPKO Health (OPK) United States $0.906B 0.00
Silk Road Medical (SILK) United States $0.886B 0.00
OrthoPediatrics (KIDS) United States $0.758B 0.00
Paragon 28 (FNA) United States $0.661B 0.00
Mesa Laboratories (MLAB) United States $0.651B 22.09
SiBone (SIBN) United States $0.623B 0.00
Pacific Biosciences Of California (PACB) United States $0.596B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.567B 0.00
IRadimed (IRMD) United States $0.540B 30.25
Pulse Biosciences (PLSE) United States $0.436B 0.00
Nevro (NVRO) United States $0.410B 0.00
Treace Medical Concepts (TMCI) United States $0.349B 0.00
Tactile Systems Technology (TCMD) United States $0.325B 11.11
Sight Sciences (SGHT) United States $0.289B 0.00
AxoGen (AXGN) United States $0.261B 0.00
AngioDynamics (ANGO) United States $0.257B 0.00
EDAP TMS S.A (EDAP) France $0.256B 0.00
NeuroPace (NPCE) United States $0.246B 0.00
908 Devices (MASS) United States $0.237B 0.00
Inogen (INGN) United States $0.211B 0.00
Atossa Genetics (ATOS) United States $0.202B 0.00
Delcath Systems (DCTH) United States $0.193B 0.00
Alpha Tau Medical (DRTS) Israel $0.186B 0.00
ClearPoint Neuro (CLPT) United States $0.175B 0.00
CVRx (CVRX) United States $0.174B 0.00
Semler Scientific (SMLR) United States $0.167B 8.48
Accuray (ARAY) United States $0.166B 0.00
KORU Medical Systems (KRMD) United States $0.108B 0.00
Yubo Biotech (YBGJ) China $0.106B 0.00
Sensus Healthcare (SRTS) United States $0.105B 22.14
Spectral Diagnostics (EDTXF) Canada $0.097B 0.00
Neuronetics (STIM) United States $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.061B 0.00
Envoy Medical (COCH) United States $0.059B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
SEP Acquisition (SEPA) United States $0.057B 0.00
DarioHealth (DRIO) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.049B 0.00
LENSAR (LNSR) United States $0.047B 0.00
Autonomix Medical (AMIX) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
ReWalk Robotics (LFWD) Israel $0.044B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.035B 0.00
Aspira Women's Health (AWH) United States $0.033B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.026B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
Biosig Technologies (BSGM) United States $0.018B 0.00
PAVmed (PAVM) United States $0.018B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.017B 0.00
NexGel (NXGL) United States $0.014B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00